APA

Frías M., Rodríguez-Cano D., Cuenca-López F., Macías J., Gordon A., Manzanares-Martín B., Pineda J. A., Camacho Á., Torre-Cisneros J., Peña J., Rivero-Juárez A. & Rivero A. (20180718). HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients. : The pharmacogenomics journal.

Chicago

Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda J A, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A and Rivero A. 20180718. HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients. : The pharmacogenomics journal.

Harvard

Frías M., Rodríguez-Cano D., Cuenca-López F., Macías J., Gordon A., Manzanares-Martín B., Pineda J. A., Camacho Á., Torre-Cisneros J., Peña J., Rivero-Juárez A. and Rivero A. (20180718). HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients. : The pharmacogenomics journal.

MLA

Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda J A, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A and Rivero A. HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients. : The pharmacogenomics journal. 20180718.